Benjamin F. Edwards & Company Inc. grew its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 15.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,775 shares of the company’s stock after purchasing an additional 7,602 shares during the quarter. Benjamin F. Edwards & Company Inc.’s holdings in Clorox were worth $7,611,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Core Wealth Advisors Inc. purchased a new position in Clorox during the fourth quarter worth approximately $29,000. Innealta Capital LLC acquired a new position in shares of Clorox during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC lifted its position in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares in the last quarter. GoalVest Advisory LLC acquired a new stake in Clorox in the 1st quarter valued at $31,000. Finally, First Foundation Advisors purchased a new stake in Clorox in the 1st quarter worth $31,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.51% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on CLX
Clorox Trading Up 0.8 %
Shares of CLX opened at $163.33 on Friday. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The firm has a 50-day moving average price of $149.14 and a 200 day moving average price of $143.78. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.09. The firm has a market capitalization of $20.28 billion, a P/E ratio of 84.63, a P/E/G ratio of 3.29 and a beta of 0.40.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Sell-side analysts forecast that The Clorox Company will post 6.63 EPS for the current year.
Clorox Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.99%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- What is the NASDAQ Stock Exchange?
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- How to Invest in Insurance Companies: A GuideĀ
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Airline Stocks – Top Airline Stocks to Buy Now
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.